Heart Cells Foundation Creating A New Field Of Medicine
Heart Cells Foundation – Creating a new field of medicine in the 21st Century. The ability to use a person’s own Stem Cells to repair their heart is revolutionising the practice of medicine. Our goal is to make this treatment readily available to everyone.
As leaders in the field with respect to Regenerative Medicine to treat Heart Failure, the charity is committed to continue its work to ensure that the power of stem cells is realised.
Having funded Phase I and II of the Regenerate Trials, we are currently planning and fundraising for Phase III, this will ensure that the ground breaking treatment can be adopted by the NHS and beyond.
The charity funds the Compassionate Treatment Programme headed by Professor Anthony Mathur at St Bartholomew’s Hospital treating patients with their own Stem Cells to regenerate their damaged heart. This is the first unit of its kind in Europe.
The Heart Cells Foundation chair is Jenifer Rosenberg OBE who is pictured here with her late husband, Ian, and Professor Anthony Mathur.
On his return, Ian Rosenberg’s quality of life was improved and he was shocked to find no patient trials of the procedure in the UK. He then decided to set up the Heart Cells Foundation to raise money to fund ground-breaking cardiac stem cell trials at Barts and London NHS Trust.
Ian Rosenberg, Founder of the pioneering Heart Cells Foundation, died on 25th August 2006, aged 70. In 2003 he was given just 2 months to live. It was then that he heard about cardiac stem cell therapy and travelled to Germany with Anthony Mathur to receive treatment.
A revolutionary treatment
Adult stem cells are the body’s building blocks. They are like a natural repair system, which doctors believe could help treat heart disease. Trials show that a patient’s own stem cells may be able to restore damaged heart tissue.
Why we need your help
The Heart Cells Foundation is funding further research and the creation of a special unit at the Barts and The London NHS Trust. Your support will help a world-class medical team develop this potentially life-saving therapy in the UK.